Stock Earnings

Question 1

CStone Pharmaceuticalsの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、CStone Pharmaceuticalsの総資産は$1,393で、純lossは$-91です。

Question 2

CSPHFの主要な財務比率は何ですか？

Accepted Answer

CStone Pharmaceuticalsの流動比率は1.35、純利益率は-22.35、1株当たり売上高は$0.31です。

Question 3

CStone Pharmaceuticalsの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

CStone Pharmaceuticals largest revenue segment is Biopharmaceutical Products, at a revenue of 512,544,470 in the most earnings release.For geography, China (excluding Hong Kong and Taiwan) is the primary market for CStone Pharmaceuticals, at a revenue of 409,107,819.

Question 4

CStone Pharmaceuticalsは収益を上げていますか？

Accepted Answer

no、最新の財務諸表によると、CStone Pharmaceuticalsの純lossは$-91です。

Question 5

CStone Pharmaceuticalsに負債はありますか？

Accepted Answer

yes、CStone Pharmaceuticalsの負債は1,029です。

Question 6

CStone Pharmaceuticalsの発行済株式数は何株ですか？

Accepted Answer

CStone Pharmaceuticalsの総発行済株式数は1,284.23株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	202	407	463	481	243	1,038
Revenue Growth (YoY)	-56%	-12%	-4%	98%	-77%	--
Cost of Revenue	227	167	159	202	106	241
Gross Profit	-24	240	304	278	136	797
Selling, General & Admin	181	211	382	576	661	484
Research & Development	162	123	501	590	1,304	1,404
Operating Expenses	329	322	857	1,158	1,930	1,859
Other Non Operating Income (Expenses)	--	-3	-1	--	--	--
Pretax Income	-377	-91	-367	-902	-1,920	-1,220
Income Tax Expense	--	--	--	--	--	--
Net Income	-377	-91	-367	-902	-1,920	-1,220
Net Income Growth	165%	-75%	-59%	-53%	56.99%	-41%
Shares Outstanding (Diluted)	1,314.13	1,276.19	1,263.07	1,172.83	1,165.2	1,046.03
Shares Change (YoY)	3%	1%	8%	1%	11%	21%
EPS (Diluted)	-0.28	-0.07	-0.29	-0.76	-1.64	-1.16
EPS Growth	159%	-75%	-62%	-53%	41%	-51%
Free Cash Flow	-430	-343	-653	-714	-1,633	-579
Free Cash Flow Per Share	-0.32	-0.26	-0.51	-0.6	-1.4	-0.55
Gross Margin	-11.88%	58.96%	65.65%	57.79%	55.96%	76.78%
Operating Margin	-175.24%	-19.9%	-119.43%	-182.95%	-737.86%	-102.31%
Profit Margin	-186.63%	-22.35%	-79.26%	-187.52%	-790.12%	-117.53%
Free Cash Flow Margin	-212.87%	-84.27%	-141.03%	-148.44%	-672.01%	-55.78%
EBITDA	--	-32	-495	-836	-1,771	-1,048
EBITDA Margin	--	-7.86%	-106.91%	-173.8%	-728.8%	-100.96%
D&A For EBITDA	--	49	58	44	22	14
EBIT	-354	-81	-553	-880	-1,793	-1,062
EBIT Margin	-175.24%	-19.9%	-119.43%	-182.95%	-737.86%	-102.31%
Effective Tax Rate	--	--	--	--	--	--

CStone Pharmaceuticals (CSPHF) Price

CSPHF Stock Price Chart

CSPHF Income

Follow-Up Questions